"The Neurology Center of Southern California is the premier neurologic medical group in North San Diego County dedicated to Excellence in Neurologic Care and Research. The Neurology Center provides diagnostic treatment services for patients with disorders of the nervous system. While our providers practice general neurology, each has unique capabilities and interests. Our areas of expertise include treatment for Alzheimer’s, Parkinson’s Disease, Stroke, Headache Medicine, Botox Therapy, Multiple Sclerosis, Myasthenia Gravis, Sleep Medicine, Epilepsy Monitoring, Movement Disorders, Neuro Ophthalmology, Neuro-Oncology, Nerve and Muscle Disorders, Neuropsychological Testing, and Interventional Pain Management."

During the past decade, The Research Center of Southern California conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 9 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Research Center of Southern California" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials, followed by "Eisai Inc." with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Alexion" with 1 trials sponsored and "AstraZeneca" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Research Center of Southern California" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Clinvest" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "The Research Center of Southern California" are "Alzheimer's Disease" (5 trials), "Migraine" (3 trials), "Multiple Sclerosis" (3 trials), "Migraine Disorders" (2 trials) and "Acute Migraine" (1 trials). Many other conditions were trialed in "The Research Center of Southern California" in a lesser frequency.

Most popular intervention types in "The Research Center of Southern California" are "Drug" (19 trials), "Device" (3 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Placebo Control" (2 trials) and "ARMS Questionnaire" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Research Center of Southern California" are 23 trials for "All" genders.

Currently, there are NaN active trials in "The Research Center of Southern California". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in The Research Center of Southern California, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The Research Center of Southern California, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

The Research Center of Southern California has several departments that took part in Clinical trials: "North County Neurology Associates" - 6 trials